Inventor · disambiguated record
Michiel De Vries
Also filed as: DE VRIES MICHIEL · DE VRIES MICHIEL H · DE VRIES MICHIEL HENRICUS
4 granted patents·10 pending applications·19 citations·filing 2003–2022
71Inventor score
Files withSOLVAY PHARM BV4MEDIVATION PROSTATE THERAPEUTICS LLC3SOLVAY PHARM GMBH2ASAHI PHARMA CO LTD1BOURIN MICHEL1
Top patents by PatentIndex Score
14 records- 0184US7964604B2Bifeprunox mesylate maintenance dose compositions and methods for using the sameSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·10 cites·34 claims
- 0272US7423040B2Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using sameEIJGENDAAL IRENE·Filed 2006·Granted Sep 9, 2008·6 cites·30 claims
- 0367US7087620B2Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to anti-arrhythmic eventsSOLVAY PHARM GMBH·Filed 2003·Granted Aug 8, 2006·3 cites·17 claims
- 0466US12161628B2Combination therapyMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2022·Granted Dec 10, 2024·0 cites·6 claims
- 0552US2009068290A1Bifeprunox doses for treating schizophreniaBOURIN MICHEL·Filed 2007·Application pending·0 cites
- 0652US2021069166A1Combination TherapyMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 0750US2023321085A1Compound for use in the treatment of dry mouthASAHI PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0848US2006013874A1Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-oneSOLVAY PHARM BV·Filed 2005·Application pending·0 cites
- 0947US2018228790A1Combination Therapy with ApalutamideMEDIVATION TECH LLC·Filed 2016·Application pending·0 cites
- 1047US2007082905A1Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using sameDE VRIES MICHIEL H·Filed 2006·Application pending·0 cites
- 1146US2011200687A1Bifeprunox mesylate maintenance dose compositions and methods for using the sameSOLVAY PHARM BV·Filed 2011·Application pending·0 cites
- 1244US2005261300A1Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic eventsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 1343US2011070319A1Bifeprunox doses for treating schizophreniaSOLVAY PHARM BV·Filed 2010·Application pending·0 cites
- 1441US2018235935A1Treatment of Cancer with Enzalutamide and a CYP3A4 InhibitorMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →